Wasim Q. Malik
InvestorGeneral Partner at IASO NEUROIMPACT · Managing Partner at Iaso Ventures
Boston, Massachusetts
Writes $100K – $2.5M checks · typically $500K
Find your path to Wasim
2,378 people in our graph can introduce you to Wasim.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jessica Sagers to introduce you to Wasim
You →Jessica · together at Harvard Medical School and Massachusetts General Hospital (2014–2019) →Wasim
Ask Jamie Chen to introduce you to Wasim
You →Jamie · 3 people · together at Health Catalyst →Wasim
Ask Sam Okafor to introduce you to Wasim
You →Sam · 2 people · together at Roivant Sciences →Wasim
Sign up to find every way you can get introduced to Wasim
- Your email: the people you already email who know Wasim
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Wasim
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Managing Partner overseeing Iaso Ventures' strategy, investments and partnerships. Previously the first Chief Digital Strategist at Roivant Sciences, and a longtime research faculty member at Massachusetts General Hospital/Harvard Medical School and educator at MIT. Holds a DPhil in electrical engineering from Oxford, with postdoctoral neuroscience training at MIT and finance education from Harvard Business School.
Contact· self-published, not guessed
Experience
- Iaso VenturesManaging Partnercurrent2020 — presentBoston, MA
- Harvard Medical School and Massachusetts General HospitalDirector of Biomarker Research, Department of Psychiatrycurrent2008 — presentBoston, MA
- Epilepsy FoundationChair of the Board’s Research Committee & Board Membercurrent2019 — present
- Massachusetts Institute of TechnologyResearch Affiliate, Department of Brain & Cognitive Sciencescurrent2007 — presentCambridge, MA
- Prudentia SciencesFounding Board Membercurrent2023 — presentBoston, Massachusetts, United States
- Scaffold TherapeuticsBoard Membercurrent2022 — presentBoston, Massachusetts, United States
- ClexBioIndependent Board Membercurrent2022 — presentOslo, Norway
- Beacon BiosignalsAdvisorcurrent2025 — presentBoston, Massachusetts, United States
- ZafrensAdvisorcurrent2023 — presentSan Diego, California, United States
- Celéri HealthAdvisorcurrent2022 — present
- Voting Rights BrigadeBoard Membercurrent2022 — present
- VC UniversityMentor2023 — 2024
- Broad Institute of MIT and HarvardSenior Advisor, Count Me In2023 — 2024Cambridge, Massachusetts, United States
- HoneywellAdvisor, Healthcare Solutions2022 — 2024
- Endless Frontier LabsStartup Mentor, Life Sciences2019 — 2022Greater New York City Area
- Health CatalystSenior Advisor, Life Sciences2019 — 2022Greater Boston Area
- Creative Destruction LabStartup Mentor2018 — 2022
- Pragma BioAdvisor2021San Francisco, California, United States
- MIT Alumni Angels of BostonAngel Investor2018 — 2021Boston, MA
- SaphetorIndependent Board Member2019 — 2020Lausanne, Switzerland
- Mirrored Motion Works (MMW)Advisor2019 — 2020Raleigh-Durham, North Carolina
- Dreamit VenturesStartup Mentor, Health-tech2018 — 2020Philadelphia, PA
- Sky Ventures GroupAngel Investor2018 — 2020Boston, MA
- MyolexAdvisor2018 — 2020Greater Boston Area
- monARC BionetworksBoard Member2018 — 2019San Francisco, MA
- Roivant SciencesChief Digital Strategist2017 — 2019New York, NY
- Brown UniversityVisiting Scientist, BrainGate Laboratory for Restorative Neurotechnology2009 — 2017Providence, Rhode Island Area
- University of OxfordResearch Fellow2005 — 2007Oxford, UK
- Nortel NetworksSystems Analyst2001 — 2002Harlow, UK
- Wolfetech CorpSoftware Engineer2000 — 2001Claremont, CA
- Elixir TechnologiesSoftware Engineer2000
Skills & more
+12 more
Statistical ModelingVenture CapitalArtificial intelligenceBusiness StrategyPharmaceutical IndustryHealthcarePythonManagementLeadershipStrategic PartnershpisExecutive LeadershipStart-up VenturesFrom Wasim's professional profile.
Investments
Led
ClexbioHexokine TherapeuticsScaffold TherapeuticsZenith Health
Investor
Catena BiosciencesCeleri HealthDeep 6 AIEpiwatchMensura HealthNeurauraNeurona TherapeuticsPrudentia SciencesRyghtSoovuZafrens
Per curated public sources.
Frequently asked questions
- Who is Wasim Q. Malik?
- Managing Partner overseeing Iaso Ventures' strategy, investments and partnerships. Previously the first Chief Digital Strategist at Roivant Sciences, and a longtime research faculty member at Massachusetts General Hospital/Harvard Medical School and educator at MIT. Holds a DPhil in electrical engineering from Oxford, with postdoctoral neuroscience training at MIT and finance education from Harvard Business School.
- Where does Wasim Q. Malik work?
- Wasim Q. Malik is General Partner at IASO NEUROIMPACT.
- What check size does Wasim Q. Malik write?
- Wasim Q. Malik typically writes checks of $100K – $2.5M.
- What companies has Wasim Q. Malik invested in?
- Investments tracked here include Clexbio, Hexokine Therapeutics, Scaffold Therapeutics, Zenith Health, Catena Biosciences, Celeri Health, Deep 6 AI, Epiwatch, Mensura Health, Neuraura, Neurona Therapeutics, Prudentia Sciences, and 3 more.
- Where did Wasim Q. Malik go to school?
- Wasim Q. Malik studied at University of Oxford (Ph.D., Electrical Engineering); Massachusetts Institute of Technology (Postdoc, Computational Neuroscience); Harvard Business School (Executive Education, Venture Capital and Private Equity).
- Does Wasim Q. Malik lead rounds?
- Yes — Wasim Q. Malik has led 4 tracked investments.
Same school
Also attended University of Oxford1,756
+ 1,750 more
Also attended Massachusetts Institute of Technology2,000
+ 1,994 more
Also attended Harvard Business School2,000
+ 1,994 more
Also attended Saïd Business School, University of Oxford453
+ 447 more
Shared employers
Also worked at Massachusetts Institute of Technology885
+ 879 more
Also worked at Prudentia Sciences3
Also worked at Honeywell183
+ 177 more
Also worked at Endless Frontier Labs32
+ 26 more































































